B-Lymphocyte Antigen CD19 (CD19) Antibody,Abbexa,abx015793
The CD19 antigen (95kDa) is expressed from the earliest stage of B progenitor development, on all peripheral B cells including germinal centre B cells, and all B cell lines and B cell leukaemia tested.T cell and monocytic cell lines are negative and the antigen is lost on B cell maturation to plasma cells.The antigen is a type I integral membrane glycoprotein whose in vitro inhibition will influence B cell activation and proliferation.
Host
Mouse
Reactivity
Human
Application
ELISA, IF/ICC, FCM
Conjugate
Unconjugated
Platform ID
BAB314252519
Abbexa
Contact
Tel: +44 (0) 1223 755950
Fax: +44 (0) 1223 755951
Email:
Product Specifications
Specifications
NameB-Lymphocyte Antigen CD19 (CD19) Antibody
Cat. No.abx015793
Accession NumberP15391
Gene ID (Entrez)930
HostMouse
IsotypeIgG2b
ReactivityHuman
ConjugationUnconjugated
ApplicationELISA, IF/ICC, FCM
Working DilutionsELISA: 1/10000, IF/ICC: 1/200 - 1/1000, FCM: 1/200 - 1/400. Optimal dilutions/concentrations should be determined by the end user.
ClonalityMonoclonal
ConcentrationNot determined.
Molecular Weight61 kDa
TargetCD19
ImmunogenPurified recombinant fragment of human CD19 expressed in E. coli.
PurityUnpurified ascites.
Appearance/FormLiquid
FormulationAscitic fluid containing 0.03% sodium azide.
StorageAliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Regulatory StatusResearch Use Only
Category Paths
- Products>Primary Antibodies>Monoclonal Antibodies
Request a product
Please provide the required information below so that we can quickly source your products.